Skip to content
Clinical Trial Events
Outsourcing in Clinical Trials West Coast (OCT West)

Panel Clinical Data Management track

Panel discussion: Choosing an outsourcing model: FSO vs FSP vs inhouse

Wed, Feb 12, 2025 · 10:00–10:30 AM PST Hyatt Regency San Francisco Airport

About this session

- Weighing up pros and cons of different outsourcing models: which is best for your trial?

- When is mixing and matching better than fully outsourcing or keeping trials fully in house?

- Developing an outsourcing strategy as a small to medium sized biotech with limited resources

- Why is FSP becoming a popular choice among sponsor companies and how can this support meeting trial timelines?

- How do strategic alliances impact this decision?

Speakers

  • Joshua Cox

    Vice President, Clinical Data & Analytics Capabilities · Eli Lilly and Company

    Panelist

  • Hayley Lane

    Vice President Clinical Operations · Star Therapeutics

    Panelist

  • Ros Cheetham

    Vice President of Clinical Operations · MacroGenics

    Panelist

  • Thomas Tremblay

    Vice President, Head of Clinical Operations · Trefoil Therapeutics

    Panelist

  • Jenni Herber

    Associate Director, Clinical Operations · Kamau Therapeutics

    Panelist